Exercise capacity can predict exacerbations and hospitalizations in a 1-year follow up in non-cystic fibrosis bronchiectasis adults

S. Rached (São Paulo, Brazil), R. Agnelo Silva De Castro (São Paulo, Brazil), A. Alves De Camargo (São Paulo, Brazil), R. Athanazio (São Paulo, Brazil), A. Cukier (São Paulo, Brazil), S. Dal Corso (São Paulo, Brazil), R. Stelmach (São Paulo, Brazil)

Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Session: Management of bronchiectasis and large airway diseases
Session type: Thematic Poster
Number: 786
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Rached (São Paulo, Brazil), R. Agnelo Silva De Castro (São Paulo, Brazil), A. Alves De Camargo (São Paulo, Brazil), R. Athanazio (São Paulo, Brazil), A. Cukier (São Paulo, Brazil), S. Dal Corso (São Paulo, Brazil), R. Stelmach (São Paulo, Brazil). Exercise capacity can predict exacerbations and hospitalizations in a 1-year follow up in non-cystic fibrosis bronchiectasis adults. 786

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Factors associated with length of stay of hospitalised exacerbations for non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019


The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013

GORD/PPI and exacerbations in adults with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.
Source: International Congress 2019 – Clinical problems
Year: 2019

Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019

A comparison of in-hospital and HITH-based treatment of respiratory exacerbations in children with bronchiectasis
Source: International Congress 2019 – Novel findings in paediatric respiratory infections
Year: 2019

Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period
Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease
Year: 2015


Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2007; 30: Suppl. 51, 528s
Year: 2007

The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit
Source: International Congress 2018 – Orphan diseases in children
Year: 2018


HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


The COPD Assessment Test in patients with non-cystic fibrosis bronchiectasisundergoing pulmonary rehabilitation
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018



Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016